| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | -0.13 | 0.02 |
| mRNA | AZD-7545 | CTRPv2 | pan-cancer | AAC | 0.084 | 0.02 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | -0.078 | 0.02 |
| mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.072 | 0.02 |
| mRNA | KU-55933 | GDSC1000 | pan-cancer | AAC | -0.079 | 0.03 |
| mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.03 |
| mRNA | CEP-701 | GDSC1000 | pan-cancer | AAC | -0.072 | 0.03 |
| mRNA | JNJ-26854165 | GDSC1000 | pan-cancer | AAC | -0.074 | 0.03 |
| mRNA | PFI-1 | GDSC1000 | pan-cancer | AAC | 0.07 | 0.04 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | -0.071 | 0.04 |